Shield Therapeutics (STX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

7.00p
   
  • Change Today:
    -0.75p
  • 52 Week High: 8.06p
  • 52 Week Low: 2.25p
  • Currency: UK Pounds
  • Shares Issued: 1,041.69m
  • Volume: 9,699,001
  • Market Cap: £72.92m

Latest ShareCast News

Shield Therapeutics inks exclusive licence agreement in Japan

By Iain Gilbert

Date: Tuesday 22 Apr 2025

(Sharecast News) - Pharmacitucal firm Shield Therapeutics said on Tuesday that it had inked an exclusive licence agreement for its ACCRUFeR iron deficiency asset in Japan with VITAL-NET.

Shield Therapeutics appoints Anders Lundstrom as permanent CEO

By Josh White

Date: Monday 27 Jan 2025

(Sharecast News) - Shield Therapeutics announced the appointment of Anders Lundstrom as its permanent chief executive officer on Monday, effective 1 February.

Shield Therapeutics secures $10m investment, announces RetailBook offer

By Josh White

Date: Friday 06 Dec 2024

(Sharecast News) - Shield Therapeutics announced on Friday that it has secured a $10m investment from its largest shareholder, AOP Health International Management, through a subscription of 256.4 million new shares at 3p per share.

Shield Therapeutics reports strong quarter for A... 29-Oct-2024 ShareCast
Shield Therapeutics announces promising paediatr... 25-Sep-2024 ShareCast
Shield Therapeutics iron deficiency treatment ap... 27-Aug-2024 ShareCast
Shield Therapeutics net sales grow in Q2, CEO st... 24-Jul-2024 ShareCast
Shield Therapeutics reports strong US progress 07-Dec-2023 ShareCast
Shield's Canadian partner files new drug submiss... 21-Mar-2022 ShareCast
Shield Therapeutics revenue falls in line with e... 17-Feb-2022 ShareCast
Shield Therapeutics enters Accrufer licensing de... 05-Jan-2022 ShareCast
Shield shares surge on expansion of US coverage ... 16-Dec-2021 ShareCast
Shield Therapeutics appoints chief medical officer 27-Sep-2021 ShareCast
Shield Therapeutics swings to losses in first half 17-Aug-2021 ShareCast
Shield Therapeutics inks exclusive licence for '... 12-Aug-2021 ShareCast
Shield Therapeutics appoints industry veteran Gr... 28-May-2021 ShareCast
Shield taps Hans-Peter Rudolf as its new finance... 22-Mar-2021 ShareCast
Shield's Feraccru gets registration in Australia 09-Mar-2021 ShareCast
Shield Therapeutics FY trading in line with mark... 15-Jan-2021 ShareCast
Shield shares rise as Teva withdraws patent oppo... 19-Oct-2020 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

STX Market Data

Currency UK Pounds
Share Price 7.00p
Change Today -0.75p
% Change -9.68 %
52 Week High 8.06p
52 Week Low 2.25p
Volume 9,699,001
Shares Issued 1,041.69m
Market Cap £72.92m

STX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
12.49% below the market average12.49% below the market average12.49% below the market average12.49% below the market average12.49% below the market average
70.73% above the sector average70.73% above the sector average70.73% above the sector average70.73% above the sector average70.73% above the sector average
Price Trend
58.74% above the market average58.74% above the market average58.74% above the market average58.74% above the market average58.74% above the market average
77.27% above the sector average77.27% above the sector average77.27% above the sector average77.27% above the sector average77.27% above the sector average
Income Not Available
Growth
64.03% above the market average64.03% above the market average64.03% above the market average64.03% above the market average64.03% above the market average
79.31% above the sector average79.31% above the sector average79.31% above the sector average79.31% above the sector average79.31% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

STX Dividends

No dividends found

Trades for 29-Aug-2025

Time Volume / Share Price
16:29 455 @ 7.10p
16:29 141,022 @ 6.90p
16:23 11,000 @ 7.09p
16:22 90,000 @ 6.96p
16:18 21,116 @ 7.08p

STX Key Personnel

CEO Anders Lundstrom

Top of Page